132 related articles for article (PubMed ID: 34855795)
1. SARS-CoV-2 spike protein displays sequence similarities with paramyxovirus surface proteins; a bioinformatics study.
Ahmadi E; Zabihi MR; Hosseinzadeh R; Mohamed Khosroshahi L; Noorbakhsh F
PLoS One; 2021; 16(12):e0260360. PubMed ID: 34855795
[TBL] [Abstract][Full Text] [Related]
2. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
[TBL] [Abstract][Full Text] [Related]
3. Using bioinformatic protein sequence similarity to investigate if SARS CoV-2 infection could cause an ocular autoimmune inflammatory reactions?
Karagöz IK; Munk MR; Kaya M; Rückert R; Yıldırım M; Karabaş L
Exp Eye Res; 2021 Feb; 203():108433. PubMed ID: 33400927
[TBL] [Abstract][Full Text] [Related]
4. Identification of three conserved linear B cell epitopes on the SARS-CoV-2 spike protein.
Wang A; Tian Y; Liu H; Ding P; Chen Y; Liang C; Du Y; Jiang D; Zhu X; Yin J; Zhang G
Emerg Microbes Infect; 2022 Dec; 11(1):2120-2131. PubMed ID: 35916768
[TBL] [Abstract][Full Text] [Related]
5. Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.
Gupta AM; Chakrabarti J; Mandal S
Microbes Infect; 2020; 22(10):598-607. PubMed ID: 33049387
[TBL] [Abstract][Full Text] [Related]
6. Spike protein fusion loop controls SARS-CoV-2 fusogenicity and infectivity.
Pal D
J Struct Biol; 2021 Jun; 213(2):107713. PubMed ID: 33662570
[TBL] [Abstract][Full Text] [Related]
7. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
[TBL] [Abstract][Full Text] [Related]
8. Immunoinformatic analysis of structural and epitope variations in the spike and Orf8 proteins of SARS-CoV-2/B.1.1.7.
Hussain M; Shabbir S; Amanullah A; Raza F; Imdad MJ; Zahid S
J Med Virol; 2021 Jul; 93(7):4461-4468. PubMed ID: 33704818
[TBL] [Abstract][Full Text] [Related]
9. Low-sugar universal mRNA vaccine against coronavirus variants with deletion of glycosites in the S2 or stem of SARS-CoV-2 spike messenger RNA (mRNA).
Cheng CW; Wu CY; Wang SW; Chen JY; Kung CC; Liao KS; Wong CH
Proc Natl Acad Sci U S A; 2023 Dec; 120(49):e2314392120. PubMed ID: 38011546
[TBL] [Abstract][Full Text] [Related]
10. Priming of SARS-CoV-2 S protein by several membrane-bound serine proteinases could explain enhanced viral infectivity and systemic COVID-19 infection.
Fuentes-Prior P
J Biol Chem; 2021; 296():100135. PubMed ID: 33268377
[TBL] [Abstract][Full Text] [Related]
11. Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve
Shiliaev N; Lukash T; Palchevska O; Crossman DK; Green TJ; Crowley MR; Frolova EI; Frolov I
J Virol; 2021 Oct; 95(21):e0135721. PubMed ID: 34406867
[TBL] [Abstract][Full Text] [Related]
12. Cryo-electron Microscopy Structure of the Swine Acute Diarrhea Syndrome Coronavirus Spike Glycoprotein Provides Insights into Evolution of Unique Coronavirus Spike Proteins.
Guan H; Wang Y; Perčulija V; Saeed AFUH; Liu Y; Li J; Jan SS; Li Y; Zhu P; Ouyang S
J Virol; 2020 Oct; 94(22):. PubMed ID: 32817223
[TBL] [Abstract][Full Text] [Related]
13. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19.
Xu W; Wang M; Yu D; Zhang X
Front Immunol; 2020; 11():565278. PubMed ID: 33013929
[TBL] [Abstract][Full Text] [Related]
14. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
Choudhury A; Mukherjee S
J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
[TBL] [Abstract][Full Text] [Related]
15. Targeting the SARS-CoV-2 spike glycoprotein prefusion conformation: virtual screening and molecular dynamics simulations applied to the identification of potential fusion inhibitors.
Romeo A; Iacovelli F; Falconi M
Virus Res; 2020 Sep; 286():198068. PubMed ID: 32565126
[TBL] [Abstract][Full Text] [Related]
16. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
Troyano-Hernáez P; Reinosa R; Holguín Á
Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
[TBL] [Abstract][Full Text] [Related]
17. Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein.
Fan X; Cao D; Kong L; Zhang X
Nat Commun; 2020 Jul; 11(1):3618. PubMed ID: 32681106
[TBL] [Abstract][Full Text] [Related]
18. Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using
Boon SS; Xia C; Wang MH; Yip KL; Luk HY; Li S; Ng RWY; Lai CKC; Chan PKS; Chen Z
mBio; 2021 Oct; 12(5):e0268721. PubMed ID: 34700382
[TBL] [Abstract][Full Text] [Related]
19. Epistatic models predict mutable sites in SARS-CoV-2 proteins and epitopes.
Rodriguez-Rivas J; Croce G; Muscat M; Weigt M
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35022216
[TBL] [Abstract][Full Text] [Related]
20. Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation.
Cheng MH; Zhang S; Porritt RA; Noval Rivas M; Paschold L; Willscher E; Binder M; Arditi M; Bahar I
Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25254-25262. PubMed ID: 32989130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
